These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 17568790)

  • 1. CDC25 phosphatases in cancer cells: key players? Good targets?
    Boutros R; Lobjois V; Ducommun B
    Nat Rev Cancer; 2007 Jul; 7(7):495-507. PubMed ID: 17568790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdc25 phosphatases and cancer.
    Kristjánsdóttir K; Rudolph J
    Chem Biol; 2004 Aug; 11(8):1043-51. PubMed ID: 15324805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The when and wheres of CDC25 phosphatases.
    Boutros R; Dozier C; Ducommun B
    Curr Opin Cell Biol; 2006 Apr; 18(2):185-91. PubMed ID: 16488126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdc25 phosphatases: structure, specificity, and mechanism.
    Rudolph J
    Biochemistry; 2007 Mar; 46(12):3595-604. PubMed ID: 17328562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of CDC25 phosphatases in the control of proliferation].
    Davezac N; Ducommun B; Baldin V
    Pathol Biol (Paris); 2000 Apr; 48(3):182-9. PubMed ID: 10858952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of the CDC25 phosphatases.
    Prevost GP; Brezak MC; Goubin F; Mondesert O; Galcera MO; Quaranta M; Alby F; Lavergne O; Ducommun B
    Prog Cell Cycle Res; 2003; 5():225-34. PubMed ID: 14593717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review.
    Lavecchia A; Di Giovanni C; Novellino E
    Expert Opin Ther Pat; 2010 Mar; 20(3):405-25. PubMed ID: 20166845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting transient protein-protein interactions: lessons from the Cdc25 protein tyrosine phosphatases.
    Rudolph J
    Nat Rev Cancer; 2007 Mar; 7(3):202-11. PubMed ID: 17287826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDC25A phosphatase: a rate-limiting oncogene that determines genomic stability.
    Ray D; Kiyokawa H
    Cancer Res; 2008 Mar; 68(5):1251-3. PubMed ID: 18316586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What if higher plants lack a CDC25 phosphatase?
    Boudolf V; Inzé D; De Veylder L
    Trends Plant Sci; 2006 Oct; 11(10):474-9. PubMed ID: 16949857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle control by the CDC25 phosphatases.
    Aressy B; Ducommun B
    Anticancer Agents Med Chem; 2008 Dec; 8(8):818-24. PubMed ID: 19075563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct modes of deregulation of the proto-oncogenic Cdc25A phosphatase in human breast cancer cell lines.
    Löffler H; Syljuåsen RG; Bartkova J; Worm J; Lukas J; Bartek J
    Oncogene; 2003 Nov; 22(50):8063-71. PubMed ID: 14603247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-3-3 Proteins--a focus on cancer and human disease.
    Wilker E; Yaffe MB
    J Mol Cell Cardiol; 2004 Sep; 37(3):633-42. PubMed ID: 15350836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing is everything: regulation of Cdk1 and aneuploidy.
    Tsichlis PN; Hatziapostolou M; Hinds PW
    Dev Cell; 2007 Apr; 12(4):477-9. PubMed ID: 17419986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC25 dual-specificity protein phosphatases: detection and activity measurements.
    Dalal SN; Volkening M
    Methods Mol Biol; 2005; 296():329-44. PubMed ID: 15576942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy.
    Lavecchia A; Di Giovanni C; Novellino E
    Curr Med Chem; 2009; 16(15):1831-49. PubMed ID: 19442149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
    Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
    ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.
    Kar S; Wang M; Carr BI
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):831-40. PubMed ID: 18246350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14-3-3 regulates the G2/M transition in the basidiomycete Ustilago maydis.
    Mielnichuk N; Pérez-Martín J
    Fungal Genet Biol; 2008 Aug; 45(8):1206-15. PubMed ID: 18586536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of CDC25 phosphatases splice variants in human breast cancer cells.
    Albert H; Santos S; Battaglia E; Brito M; Monteiro C; Bagrel D
    Clin Chem Lab Med; 2011 Oct; 49(10):1707-14. PubMed ID: 21675940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.